gastroenterologyadvisor17h
Tremfya Approved for Moderately to Severely Active Ulcerative Colitis
The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
gastroenterologyadvisor17h
At Least 1 in 5 People Has Obesity in Each US State
Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released.
gastroenterologyadvisor17h
Bowel Preparation for Colonoscopy May Be Inadequate Due to Various Factors
Predictors of inadequate bowel preparation (IBP) in colonoscopy include use of Medicaid insurance, low education levels, current tobacco smoking, and Black race, among other factors, according to a ...
gastroenterologyadvisor17h
FDA: Liver Injury Report Prompts Labeling Update for Veozah
The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.